BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31904327)

  • 1. Persistent Keratoses in Vitiligo.
    Cupertino F; Niemeyer-Corbellini JP; Cuzzi T; Ramos-E-Silva M
    Skinmed; 2019; 17(6):380-385. PubMed ID: 31904327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Follow-up study.
    Abel EA; Cox AJ; Farber EM
    J Am Acad Dermatol; 1982 Sep; 7(3):333-40. PubMed ID: 7130492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo.
    Buckley DA; Rogers S
    Clin Exp Dermatol; 1996 Jan; 21(1):43-5. PubMed ID: 8689768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photochemotherapy (PUVA) in psoriasis and vitiligo.
    Shenoi SD; Prabhu S;
    Indian J Dermatol Venereol Leprol; 2014; 80(6):497-504. PubMed ID: 25382505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer.
    van Praag MC; Bavinck JN; Bergman W; Rosendaal FR; Mommaas AM; Bruynzeel I; Scheffer E; Vermeer BJ; Bruijn JA
    J Am Acad Dermatol; 1993 Mar; 28(3):412-7. PubMed ID: 8445056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PUVA-related punctate keratoses of the hands and feet.
    Turner RJ; Sviland L; Charlton F; Farr PM
    J Am Acad Dermatol; 2000 Mar; 42(3):476-9. PubMed ID: 10688720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PUVA keratosis in vitiligo.
    Hassab-El-Naby HM; Al-Ajmi HS; Al-Sabah HY; Kajeji MM
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):1013-4. PubMed ID: 16922962
    [No Abstract]   [Full Text] [Related]  

  • 8. Disseminated superficial actinic porokeratosis: appearance associated with photochemotherapy for psoriasis.
    Hazen PG; Carney JF; Walker AE; Stewart JJ; Engstrom CW
    J Am Acad Dermatol; 1985 Jun; 12(6):1077-8. PubMed ID: 4008702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo.
    Harrist TJ; Pathak MA; Mosher DB; Fitzpatrick TB
    Natl Cancer Inst Monogr; 1984 Dec; 66():191-6. PubMed ID: 6531028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
    Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
    Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PUVA for vitiligo and skin cancer.
    Westerhof W; Schallreuter KU
    Clin Exp Dermatol; 1997 Jan; 22(1):54. PubMed ID: 9330057
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The occurrence of vitiligo after psoralens and ultraviolet a therapy.
    Todes-Taylor N; Abel EA; Cox AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):526-32. PubMed ID: 6630615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actinic keratoses arising only on sun-exposed vitiligo skin.
    Yashiro K; Nakagawa T; Takaiwa T; Inai M
    Clin Exp Dermatol; 1999 May; 24(3):199-201. PubMed ID: 10354180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy.
    Park HS; Lee YS; Chun DK
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):578-80. PubMed ID: 12941100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
    Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
    Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PUVA treatment of vitiligo: a retrospective study of 59 patients.
    Wildfang IL; Jacobsen FK; Thestrup-Pedersen K
    Acta Derm Venereol; 1992 Aug; 72(4):305-6. PubMed ID: 1357897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.